These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Nicolau DP; Freeman CD; Belliveau PP; Nightingale CH; Ross JW; Quintiliani R Antimicrob Agents Chemother; 1995 Mar; 39(3):650-5. PubMed ID: 7793867 [TBL] [Abstract][Full Text] [Related]
55. Once-daily aminoglycoside dosing: An update on current literature. Stankowicz MS; Ibrahim J; Brown DL Am J Health Syst Pharm; 2015 Aug; 72(16):1357-64. PubMed ID: 26246292 [TBL] [Abstract][Full Text] [Related]
56. Once-daily aminoglycoside dosing. Baxter R Ann Intern Med; 1997 Feb; 126(4):330. PubMed ID: 9036808 [No Abstract] [Full Text] [Related]
57. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis. Graham AC; Mercier RC; Achusim LE; Pai MP Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688 [TBL] [Abstract][Full Text] [Related]
58. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533 [TBL] [Abstract][Full Text] [Related]
59. Carvedilol: a beta blocker with antioxidant property protects against gentamicin-induced nephrotoxicity in rats. Kumar KV; Shifow AA; Naidu MU; Ratnakar KS Life Sci; 2000 May; 66(26):2603-11. PubMed ID: 10883738 [TBL] [Abstract][Full Text] [Related]